← Open Payments lookup

JESSICA TEMM: Open Payments

NPI 1487391520 · JOPLIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$427 in 22 payments from 14 companies in 2025. Trend: 2023 $851 · 2024 $791 · 2025 $427

Food & beverage: $427
CompanyPaymentsAmount
PFIZER INC.3$59
GENZYME CORPORATION2$54
Regeneron Healthcare Solutions, Inc.2$47
Takeda Pharmaceuticals U.S.A., Inc.2$40
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$36
Aimmune Therapeutics, Inc.2$35
ABBVIE INC.2$31
Lilly USA, LLC1$27
Madrigal Pharmaceuticals1$19
AstraZeneca Pharmaceuticals LP1$18

Products named: DUPIXENT, XELJANZ, XIFAXAN, OMVOH, ENTYVIO, REZDIFFRA, ZENPEP, TEZSPIRE.

Industry payments across MO — which companies pay providers there.